PubMed:17221831
Annnotations
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-123 | Sentence | denotes | The G51S purine nucleoside phosphorylase polymorphism is associated with cognitive decline in Alzheimer's disease patients. |
| T2 | 124-328 | Sentence | denotes | Alzheimer's disease (AD) is a polygenic and multifactorial complex disease, whose etiopathology is still unclear, however several genetic factors have shown to increase the risk of developing the disease. |
| T3 | 329-400 | Sentence | denotes | Purine nucleotides and nucleosides play an important role in the brain. |
| T4 | 401-545 | Sentence | denotes | Besides their role in neurotransmission and neuromodulation, they are involved in trophic factor release, apoptosis, and inflammatory responses. |
| T5 | 546-656 | Sentence | denotes | These mediators may also have a pivotal role in the control of neurodegenerative processes associated with AD. |
| T6 | 657-968 | Sentence | denotes | In this report the distribution of the exonic G/A single nucleotide polymorphism (SNP) in purine nucleoside phosphorylase (PNP) gene, resulting in the amino acid substitution serine to glycine at position 51 (G51S), was investigated in a large population of AD patients (n=321) and non-demented control (n=208). |
| T7 | 969-1051 | Sentence | denotes | The PNP polymorphism distribution was not different between patients and controls. |
| T8 | 1052-1216 | Sentence | denotes | The polymorphism distribution was also analyzed in AD patients stratified according to differential progressive rate of cognitive decline during a 2-year follow-up. |
| T9 | 1217-1397 | Sentence | denotes | An increased representation of the PNP AA genotype was observed in AD patients with fast cognitive deterioration in comparison with that from patients with slow deterioration rate. |
| T10 | 1398-1627 | Sentence | denotes | Our findings suggest that the G51S PNP polymorphism is associated with a faster rate of cognitive decline in AD patients, highlighting the important role of purine metabolism in the progression of this neurodegenerative disorder. |
| T1 | 0-123 | Sentence | denotes | The G51S purine nucleoside phosphorylase polymorphism is associated with cognitive decline in Alzheimer's disease patients. |
| T2 | 124-328 | Sentence | denotes | Alzheimer's disease (AD) is a polygenic and multifactorial complex disease, whose etiopathology is still unclear, however several genetic factors have shown to increase the risk of developing the disease. |
| T3 | 329-400 | Sentence | denotes | Purine nucleotides and nucleosides play an important role in the brain. |
| T4 | 401-545 | Sentence | denotes | Besides their role in neurotransmission and neuromodulation, they are involved in trophic factor release, apoptosis, and inflammatory responses. |
| T5 | 546-656 | Sentence | denotes | These mediators may also have a pivotal role in the control of neurodegenerative processes associated with AD. |
| T6 | 657-968 | Sentence | denotes | In this report the distribution of the exonic G/A single nucleotide polymorphism (SNP) in purine nucleoside phosphorylase (PNP) gene, resulting in the amino acid substitution serine to glycine at position 51 (G51S), was investigated in a large population of AD patients (n=321) and non-demented control (n=208). |
| T7 | 969-1051 | Sentence | denotes | The PNP polymorphism distribution was not different between patients and controls. |
| T8 | 1052-1216 | Sentence | denotes | The polymorphism distribution was also analyzed in AD patients stratified according to differential progressive rate of cognitive decline during a 2-year follow-up. |
| T9 | 1217-1397 | Sentence | denotes | An increased representation of the PNP AA genotype was observed in AD patients with fast cognitive deterioration in comparison with that from patients with slow deterioration rate. |
| T10 | 1398-1627 | Sentence | denotes | Our findings suggest that the G51S PNP polymorphism is associated with a faster rate of cognitive decline in AD patients, highlighting the important role of purine metabolism in the progression of this neurodegenerative disorder. |
LitCoin-entities
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 3849 | 4-8 | SequenceVariant | denotes | G51S | DBSNP:rs1049564 |
| 3850 | 9-40 | GeneOrGeneProduct | denotes | purine nucleoside phosphorylase | NCBIGene:4860 |
| 3851 | 73-90 | DiseaseOrPhenotypicFeature | denotes | cognitive decline | MESH:D003072 |
| 3852 | 94-113 | DiseaseOrPhenotypicFeature | denotes | Alzheimer's disease | MESH:D000544 |
| 3853 | 114-122 | OrganismTaxon | denotes | patients | NCBITaxon:9606 |
| 3854 | 124-143 | DiseaseOrPhenotypicFeature | denotes | Alzheimer's disease | MESH:D000544 |
| 3855 | 145-147 | DiseaseOrPhenotypicFeature | denotes | AD | MESH:D000544 |
| 3856 | 522-534 | DiseaseOrPhenotypicFeature | denotes | inflammatory | MESH:D007249 |
| 3857 | 653-655 | DiseaseOrPhenotypicFeature | denotes | AD | MESH:D000544 |
| 3858 | 703-706 | SequenceVariant | denotes | G/A | DBSNP:rs1049564 |
| 3859 | 747-778 | GeneOrGeneProduct | denotes | purine nucleoside phosphorylase | NCBIGene:4860 |
| 3860 | 780-783 | GeneOrGeneProduct | denotes | PNP | NCBIGene:4860 |
| 3861 | 832-864 | SequenceVariant | denotes | serine to glycine at position 51 | DBSNP:rs1049564 |
| 3862 | 866-870 | SequenceVariant | denotes | G51S | DBSNP:rs1049564 |
| 3863 | 915-917 | DiseaseOrPhenotypicFeature | denotes | AD | MESH:D000544 |
| 3864 | 918-926 | OrganismTaxon | denotes | patients | NCBITaxon:9606 |
| 3865 | 973-976 | GeneOrGeneProduct | denotes | PNP | NCBIGene:4860 |
| 3866 | 1029-1037 | OrganismTaxon | denotes | patients | NCBITaxon:9606 |
| 3867 | 1103-1105 | DiseaseOrPhenotypicFeature | denotes | AD | MESH:D000544 |
| 3868 | 1106-1114 | OrganismTaxon | denotes | patients | NCBITaxon:9606 |
| 3869 | 1172-1189 | DiseaseOrPhenotypicFeature | denotes | cognitive decline | MESH:D003072 |
| 3870 | 1252-1255 | GeneOrGeneProduct | denotes | PNP | NCBIGene:4860 |
| 3871 | 1284-1286 | DiseaseOrPhenotypicFeature | denotes | AD | MESH:D000544 |
| 3872 | 1287-1295 | OrganismTaxon | denotes | patients | NCBITaxon:9606 |
| 3873 | 1306-1329 | DiseaseOrPhenotypicFeature | denotes | cognitive deterioration | MESH:D003072 |
| 3874 | 1359-1367 | OrganismTaxon | denotes | patients | NCBITaxon:9606 |
| 3875 | 1428-1432 | SequenceVariant | denotes | G51S | DBSNP:rs1049564 |
| 3876 | 1433-1436 | GeneOrGeneProduct | denotes | PNP | NCBIGene:4860 |
| 3877 | 1486-1503 | DiseaseOrPhenotypicFeature | denotes | cognitive decline | MESH:D003072 |
| 3878 | 1507-1509 | DiseaseOrPhenotypicFeature | denotes | AD | MESH:D000544 |
| 3879 | 1510-1518 | OrganismTaxon | denotes | patients | NCBITaxon:9606 |
| 3880 | 1600-1626 | DiseaseOrPhenotypicFeature | denotes | neurodegenerative disorder | MESH:D019636 |
LitCoin-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-123 | Sentence | denotes | The G51S purine nucleoside phosphorylase polymorphism is associated with cognitive decline in Alzheimer's disease patients. |
| T2 | 124-328 | Sentence | denotes | Alzheimer's disease (AD) is a polygenic and multifactorial complex disease, whose etiopathology is still unclear, however several genetic factors have shown to increase the risk of developing the disease. |
| T3 | 329-400 | Sentence | denotes | Purine nucleotides and nucleosides play an important role in the brain. |
| T4 | 401-545 | Sentence | denotes | Besides their role in neurotransmission and neuromodulation, they are involved in trophic factor release, apoptosis, and inflammatory responses. |
| T5 | 546-656 | Sentence | denotes | These mediators may also have a pivotal role in the control of neurodegenerative processes associated with AD. |
| T6 | 657-968 | Sentence | denotes | In this report the distribution of the exonic G/A single nucleotide polymorphism (SNP) in purine nucleoside phosphorylase (PNP) gene, resulting in the amino acid substitution serine to glycine at position 51 (G51S), was investigated in a large population of AD patients (n=321) and non-demented control (n=208). |
| T7 | 969-1051 | Sentence | denotes | The PNP polymorphism distribution was not different between patients and controls. |
| T8 | 1052-1216 | Sentence | denotes | The polymorphism distribution was also analyzed in AD patients stratified according to differential progressive rate of cognitive decline during a 2-year follow-up. |
| T9 | 1217-1397 | Sentence | denotes | An increased representation of the PNP AA genotype was observed in AD patients with fast cognitive deterioration in comparison with that from patients with slow deterioration rate. |
| T10 | 1398-1627 | Sentence | denotes | Our findings suggest that the G51S PNP polymorphism is associated with a faster rate of cognitive decline in AD patients, highlighting the important role of purine metabolism in the progression of this neurodegenerative disorder. |
LitCoin_Mondo
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 94-113 | DiseaseOrPhenotypicFeature | denotes | Alzheimer's disease | 0004975 |
| T2 | 124-143 | DiseaseOrPhenotypicFeature | denotes | Alzheimer's disease | 0004975 |
LitCoin-SeqVar
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 4-8 | SequenceVariant | denotes | G51S |
| T2 | 866-870 | SequenceVariant | denotes | G51S |
| T3 | 1428-1432 | SequenceVariant | denotes | G51S |
LitCoin-GeneOrGeneProduct-v0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 9-40 | GeneOrGeneProduct | denotes | purine nucleoside phosphorylase |
| T2 | 229-236 | GeneOrGeneProduct | denotes | unclear |
| T3 | 262-269 | GeneOrGeneProduct | denotes | factors |
| T4 | 352-363 | GeneOrGeneProduct | denotes | nucleosides |
| T5 | 394-399 | GeneOrGeneProduct | denotes | brain |
| T6 | 491-497 | GeneOrGeneProduct | denotes | factor |
| T7 | 507-516 | GeneOrGeneProduct | denotes | apoptosis |
| T8 | 552-561 | GeneOrGeneProduct | denotes | mediators |
| T9 | 578-585 | GeneOrGeneProduct | denotes | pivotal |
| T10 | 627-636 | GeneOrGeneProduct | denotes | processes |
| T11 | 747-778 | GeneOrGeneProduct | denotes | purine nucleoside phosphorylase |
| T12 | 808-818 | GeneOrGeneProduct | denotes | amino acid |
| T13 | 890-894 | GeneOrGeneProduct | denotes | in a |
| T14 | 895-900 | GeneOrGeneProduct | denotes | large |
| T15 | 1197-1200 | GeneOrGeneProduct | denotes | a 2 |
| T16 | 1201-1205 | GeneOrGeneProduct | denotes | year |
| T17 | 1301-1305 | GeneOrGeneProduct | denotes | fast |
| T18 | 1373-1377 | GeneOrGeneProduct | denotes | slow |
| T19 | 1402-1410 | GeneOrGeneProduct | denotes | findings |
LitCoin-GeneOrGeneProduct-v2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 9-40 | GeneOrGeneProduct | denotes | purine nucleoside phosphorylase |
| T2 | 229-236 | GeneOrGeneProduct | denotes | unclear |
| T3 | 352-363 | GeneOrGeneProduct | denotes | nucleosides |
| T4 | 394-399 | GeneOrGeneProduct | denotes | brain |
| T5 | 491-497 | GeneOrGeneProduct | denotes | factor |
| T6 | 507-516 | GeneOrGeneProduct | denotes | apoptosis |
| T7 | 747-778 | GeneOrGeneProduct | denotes | purine nucleoside phosphorylase |
| T8 | 808-818 | GeneOrGeneProduct | denotes | amino acid |
| T9 | 895-900 | GeneOrGeneProduct | denotes | large |
| T10 | 1301-1305 | GeneOrGeneProduct | denotes | fast |
| T11 | 1373-1377 | GeneOrGeneProduct | denotes | slow |
LitCoin-Disease-MeSH
| Id | Subject | Object | Predicate | Lexical cue | originalLabel |
|---|---|---|---|---|---|
| T1 | 73-90 | DiseaseOrPhenotypicFeature | denotes | cognitive decline | D060825 |
| T2 | 94-113 | DiseaseOrPhenotypicFeature | denotes | Alzheimer's disease | D000544 |
| T3 | 124-143 | DiseaseOrPhenotypicFeature | denotes | Alzheimer's disease | D000544 |
| T4 | 145-147 | DiseaseOrPhenotypicFeature | denotes | AD | D000544 |
| T5 | 191-198 | DiseaseOrPhenotypicFeature | denotes | disease | D004194 |
| T6 | 320-327 | DiseaseOrPhenotypicFeature | denotes | disease | D004194 |
| T7 | 522-534 | DiseaseOrPhenotypicFeature | denotes | inflammatory | DISEASE |
| T8 | 653-655 | DiseaseOrPhenotypicFeature | denotes | AD | D000544 |
| T9 | 915-917 | DiseaseOrPhenotypicFeature | denotes | AD | D000544 |
| T10 | 1103-1105 | DiseaseOrPhenotypicFeature | denotes | AD | D000544 |
| T11 | 1172-1189 | DiseaseOrPhenotypicFeature | denotes | cognitive decline | D060825 |
| T12 | 1284-1286 | DiseaseOrPhenotypicFeature | denotes | AD | D000544 |
| T13 | 1486-1503 | DiseaseOrPhenotypicFeature | denotes | cognitive decline | D060825 |
| T14 | 1507-1509 | DiseaseOrPhenotypicFeature | denotes | AD | D000544 |
| T15 | 1600-1626 | DiseaseOrPhenotypicFeature | denotes | neurodegenerative disorder | D019636 |
LitCoin-GeneOrGeneProduct-v3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 9-40 | GeneOrGeneProduct | denotes | purine nucleoside phosphorylase |
| T2 | 352-363 | GeneOrGeneProduct | denotes | nucleosides |
| T3 | 747-778 | GeneOrGeneProduct | denotes | purine nucleoside phosphorylase |
| T4 | 1373-1377 | GeneOrGeneProduct | denotes | slow |
LitCoin_Mondo_095
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 94-113 | DiseaseOrPhenotypicFeature | denotes | Alzheimer's disease | 0004975 |
| T2 | 124-143 | DiseaseOrPhenotypicFeature | denotes | Alzheimer's disease | 0004975 |
| T3 | 145-147 | DiseaseOrPhenotypicFeature | denotes | AD | 0011913|0007088|0004975 |
| T6 | 653-655 | DiseaseOrPhenotypicFeature | denotes | AD | 0011913|0007088|0004975 |
| T9 | 915-917 | DiseaseOrPhenotypicFeature | denotes | AD | 0011913|0007088|0004975 |
| T12 | 1103-1105 | DiseaseOrPhenotypicFeature | denotes | AD | 0011913|0007088|0004975 |
| T15 | 1284-1286 | DiseaseOrPhenotypicFeature | denotes | AD | 0011913|0007088|0004975 |
| T18 | 1507-1509 | DiseaseOrPhenotypicFeature | denotes | AD | 0011913|0007088|0004975 |
LitCoin-MeSH-Disease-2
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T1 | 73-90 | DiseaseOrPhenotypicFeature | denotes | cognitive decline | D060825 |
| T2 | 94-113 | DiseaseOrPhenotypicFeature | denotes | Alzheimer's disease | D000544 |
| T3 | 124-143 | DiseaseOrPhenotypicFeature | denotes | Alzheimer's disease | D000544 |
| T4 | 145-147 | DiseaseOrPhenotypicFeature | denotes | AD | DISEASE|D000544 |
| T6 | 191-198 | DiseaseOrPhenotypicFeature | denotes | disease | D004194 |
| T7 | 320-327 | DiseaseOrPhenotypicFeature | denotes | disease | D004194 |
| T8 | 522-534 | DiseaseOrPhenotypicFeature | denotes | inflammatory | DISEASE |
| T9 | 653-655 | DiseaseOrPhenotypicFeature | denotes | AD | DISEASE|D000544 |
| T11 | 915-917 | DiseaseOrPhenotypicFeature | denotes | AD | DISEASE|D000544 |
| T13 | 1103-1105 | DiseaseOrPhenotypicFeature | denotes | AD | DISEASE|D000544 |
| T15 | 1172-1189 | DiseaseOrPhenotypicFeature | denotes | cognitive decline | D060825 |
| T16 | 1284-1286 | DiseaseOrPhenotypicFeature | denotes | AD | DISEASE|D000544 |
| T18 | 1306-1329 | DiseaseOrPhenotypicFeature | denotes | cognitive deterioration | DISEASE |
| T19 | 1486-1503 | DiseaseOrPhenotypicFeature | denotes | cognitive decline | D060825 |
| T20 | 1507-1509 | DiseaseOrPhenotypicFeature | denotes | AD | DISEASE|D000544 |
| T22 | 1600-1626 | DiseaseOrPhenotypicFeature | denotes | neurodegenerative disorder | D019636 |
LitCoin-MONDO_bioort2019
| Id | Subject | Object | Predicate | Lexical cue | #label |
|---|---|---|---|---|---|
| T1 | 73-90 | DiseaseOrPhenotypicFeature | denotes | cognitive decline | D060825 |
| T2 | 94-113 | DiseaseOrPhenotypicFeature | denotes | Alzheimer's disease | D000544 |
| T3 | 124-143 | DiseaseOrPhenotypicFeature | denotes | Alzheimer's disease | D000544 |
| T4 | 145-147 | DiseaseOrPhenotypicFeature | denotes | AD | DISEASE|D000544 |
| T6 | 653-655 | DiseaseOrPhenotypicFeature | denotes | AD | DISEASE|D000544 |
| T8 | 915-917 | DiseaseOrPhenotypicFeature | denotes | AD | DISEASE|D000544 |
| T10 | 1103-1105 | DiseaseOrPhenotypicFeature | denotes | AD | DISEASE|D000544 |
| T12 | 1172-1189 | DiseaseOrPhenotypicFeature | denotes | cognitive decline | D060825 |
| T13 | 1284-1286 | DiseaseOrPhenotypicFeature | denotes | AD | DISEASE|D000544 |
| T15 | 1306-1329 | DiseaseOrPhenotypicFeature | denotes | cognitive deterioration | DISEASE |
| T16 | 1486-1503 | DiseaseOrPhenotypicFeature | denotes | cognitive decline | D060825 |
| T17 | 1507-1509 | DiseaseOrPhenotypicFeature | denotes | AD | DISEASE|D000544 |
| T19 | 1600-1626 | DiseaseOrPhenotypicFeature | denotes | neurodegenerative disorder | D019636 |
LitCoin-Chemical-MeSH-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T1 | 9-40 | ChemicalEntity | denotes | purine nucleoside phosphorylase | D011683 |
| T2 | 329-335 | ChemicalEntity | denotes | Purine | http://purl.obolibrary.org/obo/CHEBI_17258 |
| T3 | 352-363 | ChemicalEntity | denotes | nucleosides | http://purl.obolibrary.org/obo/CHEBI_33838 |
| T4 | 747-778 | ChemicalEntity | denotes | purine nucleoside phosphorylase | D011683 |
| T5 | 780-783 | ChemicalEntity | denotes | PNP | http://purl.obolibrary.org/obo/CHEBI_16836 |
| T6 | 832-838 | ChemicalEntity | denotes | serine | http://purl.obolibrary.org/obo/CHEBI_17822 |
| T7 | 842-849 | ChemicalEntity | denotes | glycine | http://purl.obolibrary.org/obo/CHEBI_57305|http://purl.obolibrary.org/obo/CHEBI_29947|http://purl.obolibrary.org/obo/CHEBI_15428 |
| T10 | 973-976 | ChemicalEntity | denotes | PNP | http://purl.obolibrary.org/obo/CHEBI_16836 |
| T11 | 1252-1255 | ChemicalEntity | denotes | PNP | http://purl.obolibrary.org/obo/CHEBI_16836 |
| T12 | 1433-1436 | ChemicalEntity | denotes | PNP | http://purl.obolibrary.org/obo/CHEBI_16836 |
| T13 | 1555-1561 | ChemicalEntity | denotes | purine | C030985|http://purl.obolibrary.org/obo/CHEBI_35584 |
LitCoin-NCBITaxon-2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 114-122 | OrganismTaxon | denotes | patients |
| T2 | 918-926 | OrganismTaxon | denotes | patients |
| T3 | 1029-1037 | OrganismTaxon | denotes | patients |
| T4 | 1106-1114 | OrganismTaxon | denotes | patients |
| T5 | 1287-1295 | OrganismTaxon | denotes | patients |
| T6 | 1359-1367 | OrganismTaxon | denotes | patients |
| T7 | 1510-1518 | OrganismTaxon | denotes | patients |
LitCoin-training-merged
| Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
|---|---|---|---|---|---|---|
| T13 | 1555-1561 | ChemicalEntity | denotes | purine | http://purl.obolibrary.org/obo/CHEBI_35584|C030985 | |
| T12 | 1433-1436 | ChemicalEntity | denotes | PNP | http://purl.obolibrary.org/obo/CHEBI_16836 | |
| T11 | 1252-1255 | ChemicalEntity | denotes | PNP | http://purl.obolibrary.org/obo/CHEBI_16836 | |
| T10 | 973-976 | ChemicalEntity | denotes | PNP | http://purl.obolibrary.org/obo/CHEBI_16836 | |
| T7 | 842-849 | ChemicalEntity | denotes | glycine | http://purl.obolibrary.org/obo/CHEBI_15428|http://purl.obolibrary.org/obo/CHEBI_29947|http://purl.obolibrary.org/obo/CHEBI_57305 | |
| T6 | 832-838 | ChemicalEntity | denotes | serine | http://purl.obolibrary.org/obo/CHEBI_17822 | |
| T5 | 780-783 | ChemicalEntity | denotes | PNP | http://purl.obolibrary.org/obo/CHEBI_16836 | |
| T4 | 747-778 | ChemicalEntity | denotes | purine nucleoside phosphorylase | D011683 | |
| T3 | 352-363 | ChemicalEntity | denotes | nucleosides | http://purl.obolibrary.org/obo/CHEBI_33838 | |
| T2 | 329-335 | ChemicalEntity | denotes | Purine | http://purl.obolibrary.org/obo/CHEBI_17258 | |
| T1 | 9-40 | ChemicalEntity | denotes | purine nucleoside phosphorylase | D011683 | |
| T35685 | 1373-1377 | GeneOrGeneProduct | denotes | slow | ||
| T84050 | 747-778 | GeneOrGeneProduct | denotes | purine nucleoside phosphorylase | ||
| T5991 | 352-363 | GeneOrGeneProduct | denotes | nucleosides | ||
| T30473 | 9-40 | GeneOrGeneProduct | denotes | purine nucleoside phosphorylase | ||
| T19 | 1600-1626 | DiseaseOrPhenotypicFeature | denotes | neurodegenerative disorder | D019636 | |
| T17 | 1507-1509 | DiseaseOrPhenotypicFeature | denotes | AD | D000544|DISEASE | |
| T16 | 1486-1503 | DiseaseOrPhenotypicFeature | denotes | cognitive decline | D060825 | |
| T15 | 1306-1329 | DiseaseOrPhenotypicFeature | denotes | cognitive deterioration | DISEASE | |
| T89557 | 1284-1286 | DiseaseOrPhenotypicFeature | denotes | AD | D000544|DISEASE | |
| T68515 | 1172-1189 | DiseaseOrPhenotypicFeature | denotes | cognitive decline | D060825 | |
| T66237 | 1103-1105 | DiseaseOrPhenotypicFeature | denotes | AD | D000544|DISEASE | |
| T8 | 915-917 | DiseaseOrPhenotypicFeature | denotes | AD | D000544|DISEASE | |
| T20833 | 653-655 | DiseaseOrPhenotypicFeature | denotes | AD | D000544|DISEASE | |
| T12320 | 145-147 | DiseaseOrPhenotypicFeature | denotes | AD | D000544|DISEASE | |
| T68831 | 124-143 | DiseaseOrPhenotypicFeature | denotes | Alzheimer's disease | D000544 | |
| T37709 | 94-113 | DiseaseOrPhenotypicFeature | denotes | Alzheimer's disease | D000544 | |
| T58916 | 73-90 | DiseaseOrPhenotypicFeature | denotes | cognitive decline | D060825 | |
| T49955 | 1510-1518 | OrganismTaxon | denotes | patients | ||
| T30695 | 1359-1367 | OrganismTaxon | denotes | patients | ||
| T56412 | 1287-1295 | OrganismTaxon | denotes | patients | ||
| T92765 | 1106-1114 | OrganismTaxon | denotes | patients | ||
| T10239 | 1029-1037 | OrganismTaxon | denotes | patients | ||
| T77991 | 918-926 | OrganismTaxon | denotes | patients | ||
| T47356 | 114-122 | OrganismTaxon | denotes | patients | ||
| T4721 | 1428-1432 | SequenceVariant | denotes | G51S | ||
| T56403 | 866-870 | SequenceVariant | denotes | G51S | ||
| T61763 | 4-8 | SequenceVariant | denotes | G51S |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 9-40 | gene:4860 | denotes | purine nucleoside phosphorylase |
| T1 | 73-90 | disease:C0338656 | denotes | cognitive decline |
| T2 | 780-783 | gene:4860 | denotes | PNP |
| T3 | 915-917 | disease:C0002395 | denotes | AD |
| T4 | 1252-1255 | gene:4860 | denotes | PNP |
| T5 | 1306-1329 | disease:C0854193 | denotes | cognitive deterioration |
| T6 | 1433-1436 | gene:4860 | denotes | PNP |
| T7 | 1507-1509 | disease:C0002395 | denotes | AD |
| T8 | 1433-1436 | gene:4860 | denotes | PNP |
| T9 | 1486-1503 | disease:C0338656 | denotes | cognitive decline |
| T10 | 1433-1436 | gene:4860 | denotes | PNP |
| T11 | 1600-1626 | disease:C0524851 | denotes | neurodegenerative disorder |
| R1 | T0 | T1 | associated_with | purine nucleoside phosphorylase,cognitive decline |
| R2 | T2 | T3 | associated_with | PNP,AD |
| R3 | T4 | T5 | associated_with | PNP,cognitive deterioration |
| R4 | T6 | T7 | associated_with | PNP,AD |
| R5 | T8 | T9 | associated_with | PNP,cognitive decline |
| R6 | T10 | T11 | associated_with | PNP,neurodegenerative disorder |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 124-143 | HP_0002511 | denotes | Alzheimer's disease |
| T2 | 1172-1189 | HP_0001268 | denotes | cognitive decline |
| T3 | 1486-1503 | HP_0001268 | denotes | cognitive decline |
tmVarCorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 4-8 | ProteinMutation:p|SUB|G|51|S | denotes | G51S |
| T2 | 703-706 | DNAMutation:|SUB|G||A | denotes | G/A |
| T3 | 866-870 | ProteinMutation:p|SUB|G|51|S | denotes | G51S |
| T4 | 1428-1432 | ProteinMutation:p|SUB|G|51|S | denotes | G51S |